Annual reports Annual Report 2021 Annual Report 2020 Annual Report 2019 Annual Report 2018 Annual Report 2017 Annual Report 2016 Annual Report 2015 Annual Report 2014 Annual Report 2013 Annual Report 2012 Annual Report 2011
Åkra S, Seljeflot I, Braathen B, Bratseth V, Hansen CH, Arnesen H, Tønnessen T, Solheim S (2022) The NLRP3 inflammasome activation in subcutaneous, epicardial and pericardial adipose tissue in patients with coronary heart disease undergoing coronary by-pass surgery Atheroscler Plus, 48, 47-54 DOI 10.1016/j.athplu.2022.03.005, PubMed 36644557 Opstad TB, Nordeng J, Pettersen AR, Åkra S, Bratseth V, Zaidi H, Helseth R, Solheim S, Seljeflot I (2022) The NLRP3 Genetic Variant (rs10754555) Reduces the Risk of Adverse Outcome in Middle-Aged Patients with Chronic Coronary Syndrome J Immunol Res, 2022, 2366695 DOI 10.1155/2022/2366695, PubMed 36582742 Berge T, Myhre PL, Kalstad AA, Laake K, Tveit SH, Onarheim S, Solheim S, Seljeflot I, Arnesen H, Tveit A (2022) Screen-detected atrial fibrillation and 'micro-atrial fibrillation' and risk of cardiovascular events after myocardial infarction in elderly patients Cardiology (in press) DOI 10.1159/000528726, PubMed 36538900 More publications